1
40
4
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
25–27
Issue
3
Volume
33
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Fidaxomicin More Effective than Vancomycin for Clostridium difficile Infection in Cancer Patients?
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2013
2013-12
Subject
The topic of the resource
Cancer Patients; Randomized Controlled Trials; Double-Blind Studies; Vancomycin – Therapeutic Use; Clostridium Infections – Drug Therapy; Confidence Intervals – Utilization; Odds Ratio – Utilization; Fidaxomicin – Therapeutic Use; Recurrence – Prevention and Control
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2013
Cancer Patients
Clostridium Infections – Drug Therapy
Confidence Intervals – Utilization
Department of Internal Medicine
Double-Blind Studies
Fidaxomicin – Therapeutic Use
Infectious Disease Alert
NEOMED College of Medicine
Odds Ratio – Utilization
RANDOMIZED controlled trials
Recurrence – Prevention and Control
Vancomycin – Therapeutic Use
Watkins Richard R
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
1–2
Issue
6
Volume
36
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Vancomycin Combined with Piperacillin-Tazobactam Increases the Risk for Acute Kidney Injury.
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2017
2017-03
Subject
The topic of the resource
Antibiotics; Drug Interactions; Kidney Failure; Drug Therapy; Vancomycin; Ampicillin – Therapeutic Use; Vancomycin – Therapeutic Use; Acute – Risk Factors; Cefepime Hydrochloride – Therapeutic Use; Combination – Adverse Effects; Lactam – Adverse Effects
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Description
An account of the resource
The article comments on the retrospective cohort study "Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to those on vancomycin and cefepime" by B. Navalkele and colleagues. The study found that vancomycin paired with piperacillin-tazobactam increases the risk of acute kidney injury. It recommends clinicians to weigh the risks and benefits of vancomycin and piperacillin-tazobactam given the onset of acute kidney injury.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2017
Acute – Risk Factors
Ampicillin – Therapeutic Use
Antibiotics
Cefepime Hydrochloride – Therapeutic Use
Combination – Adverse Effects
Department of Internal Medicine
Drug Interactions
Drug Therapy
Infectious Disease Alert
Kidney Failure
Lactam – Adverse Effects
NEOMED College of Medicine
vancomycin
Vancomycin – Therapeutic Use
Watkins Richard R
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
1–2
Issue
4
Volume
36
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Fecal Transplant vs. Oral Vancomycin Taper for Recurrent Clostridium difficile Infection.
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2017
2017-01
Subject
The topic of the resource
Recurrence; Costs and Cost Analysis; Enema; Administration; Oral; Treatment Outcomes; Randomized Controlled Trials; Cost Benefit Analysis; Microbiota; Transplant Donors; Vancomycin – Therapeutic Use; Clostridium Infections – Drug Therapy; Clostridium Infections – Prevention and Control; Clostridium Infections – Therapy; Feces – Transplantation; Recurrence – Therapy; Vancomycin – Administration and Dosage; Vancomycin – Economics
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Description
An account of the resource
In a small randomized, controlled trial that compared fecal microbiota transplant (FMT) administered by enema to a six-week oral vancomycin taper, FMT was not more effective for patients with recurrent Clostridium difficile infection.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2017
Administration
Clostridium Infections – Drug Therapy
Clostridium Infections – Prevention and Control
Clostridium Infections – Therapy
Cost Benefit Analysis
Costs and Cost Analysis
Department of Internal Medicine
Enema
Feces – Transplantation
Infectious Disease Alert
Microbiota
NEOMED College of Medicine
Oral
RANDOMIZED controlled trials
Recurrence
Recurrence – Therapy
Transplant Donors
Treatment Outcomes
Vancomycin – Administration and Dosage
Vancomycin – Economics
Vancomycin – Therapeutic Use
Watkins Richard R
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
3–4
Issue
11
Volume
36
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2017
2017-08
Subject
The topic of the resource
Treatment Outcomes; Staphylococcal Infections – Drug Therapy; Treatment Outcomes – Evaluation; Bacteremia – Drug Therapy; Cefazolin – Therapeutic Use; Drug Therapy – Evaluation; Nafcillin – Therapeutic Use; Oxacillin – Therapeutic Use; Vancomycin – Therapeutic Use
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Description
An account of the resource
A retrospective study that included patients from 119 Veterans Affairs hospitals found lower mortality and a similar recurrence rate for methicillin-susceptible Staphylococcus aureus bacteremia treated with cefazolin compared to nafcillin and oxacillin.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2017
Bacteremia – Drug Therapy
Cefazolin – Therapeutic Use
Department of Internal Medicine
Drug Therapy – Evaluation
Infectious Disease Alert
Nafcillin – Therapeutic Use
NEOMED College of Medicine
Oxacillin – Therapeutic Use
Staphylococcal Infections – Drug Therapy
Treatment Outcomes
Treatment Outcomes – Evaluation
Vancomycin – Therapeutic Use
Watkins Richard R